Secukinumab improves scalp pain, itching, scaling and quality of life in patients with moderate-to-severe scalp psoriasis.
Steven R FeldmanLawrence GreenAlexa B KimballKimberly SiuYang ZhaoVivian HerreraJudit NyiradyAndrew F AlexisPublished in: The Journal of dermatological treatment (2017)
Secukinumab in moderate-to-severe scalp psoriasis reduces scalp pain, itching, and scaling and improves patients' QOL.